Matches in Nanopublications for { ?s ?p "[Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor response to anticholinesterase therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP264086.RAfD7jXt4Q86tVTeB4O4vyb1xJkBUrS6gd7Mvog36bJL4130_assertion description "[Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor response to anticholinesterase therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264086.RAfD7jXt4Q86tVTeB4O4vyb1xJkBUrS6gd7Mvog36bJL4130_provenance.
- NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_assertion description "[Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor response to anticholinesterase therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225099.RAsnZmmLFM-qDb0468e9IJZqbPYm-ozAN_r7_nY6psOo4130_provenance.
- assertion description "[Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor response to anticholinesterase therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP569353.RAUBjTcWGpz0Wc_xZ6bVqRM2ng4aI36YGq4_giBbFtfBU130_assertion description "[Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor response to anticholinesterase therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569353.RAUBjTcWGpz0Wc_xZ6bVqRM2ng4aI36YGq4_giBbFtfBU130_provenance.
- NP781044.RAHbnV9aTqwMgXtWxKC4-zhJ67ZxX9g5svCWX-mOrgrPk130_assertion description "[Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor response to anticholinesterase therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781044.RAHbnV9aTqwMgXtWxKC4-zhJ67ZxX9g5svCWX-mOrgrPk130_provenance.